Douglas W Pagan Net Worth & Insider Trades
Douglas W Pagan - Chief Financial Officer, Paratek Pharmaceuticals, Inc
What is Douglas W Pagan's Net Worth?
The current estimated net worth of Paratek Pharmaceuticals, Inc's Chief Financial Officer, Douglas W Pagan, is estimated to be about $1.37M . Douglas W Pagan owns about 134,057 units of Paratek Pharmaceuticals, Inc common stock. In the last 4 years at Paratek Pharmaceuticals, Inc, Douglas W Pagan has sold an estimated value of $698.02K worth.
What is Douglas W Pagan's Past Insider Trading?
Douglas W Pagan's largest sale order was 16,291 units , worth over $231.66K on February 7, 2018. In total, Douglas W Pagan has made about 17 transactions over 4 years of their time at Paratek Pharmaceuticals, Inc. Douglas W Pagan usually trades in February, with the busiest year in 2018. The most recent transaction was a sale order of 2,495 units , worth over $16.89K on February 7, 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Douglas W Pagan
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Douglas W Pagan's' Mailing Address?
- Mailing address is 75 Kneeland Street Boston MA 02111 MA
Paratek Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Evan Loh, M.D. | 2020 | $575,000 | - | $505,440 | $431,250 | $22,921 | $1,534,611 |
| Evan Loh, M.D. | 2019 | $520,000 | - | $1,352,100 | $364,375 | $22,521 | $2,258,996 |
| Evan Loh, M.D. | 2018 | $480,000 | - | $1,011,725 | $288,000 | $21,434 | $1,801,159 |
| Michael F. Bigham | 2020 | $500,000 | - | $473,850 | $375,000 | $24,703 | $1,373,553 |
| Michael F. Bigham | 2019 | $515,000 | - | $1,352,100 | $343,750 | $22,928 | $2,233,778 |
| Michael F. Bigham | 2018 | $500,000 | - | $1,089,550 | $330,000 | $22,890 | $1,942,440 |
| Adam Woodrow | 2020 | $445,000 | - | $236,925 | $250,313 | $16,552 | $948,790 |
| Adam Woodrow | 2019 | $415,000 | $48,375 | $676,050 | $193,500 | $15,330 | $1,348,225 |
| Adam Woodrow | 2018 | $365,000 | $35,040 | $505,862 | $140,160 | $15,369 | $1,061,431 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1178711/000120677421001229/prtk3887701-def14a.htm
What are Paratek Pharmaceuticals, Inc's Past Insider Trades?
Paratek Pharmaceuticals, Inc's most recent insider trade came on August 10, 2023 by Randall B Brenner who sold 27,603 units worth $60.73K . In the last 8 years, insiders at Paratek Pharmaceuticals, Inc have sold an estimated value of $9.41M and bought an estimated value of $14.19M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Evan Loh, CEO, Michael Bigham, Exec. Chairman the Board, and William M Haskel, CLO .
Paratek Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||